The Latest Breaking News from ALGN

Despite Align Technology’s underperformance compared to the S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Despite Align Technology’s underperformance relative to the broader market over the past year, Wall Street analysts remain moderately bullish about the stock’s prospects.

With an aging population, increasing drug demand, and the development of advanced technologies, the healthcare industry is booming. Thus, it could be wise to invest in fundamentally sound healthcare stocks, Veeva Systems (VEEV), Align Technology (ALGN), and Medpace Holdings (MEDP), which have high-profit margins. Read on.

Align Technology is all set to release its second-quarter earnings this month, and analysts project a high-single-digit bottom-line increase.

Invisalign-maker Align is setting itself up for a "show me story" with an expected uptick in growth, an analyst said Thursday as ALGN stock surged.

Invisalign maker Align Technology missed Wall Street's third-quarter expectations, and ALGN stock plummeted to a 10-month low Thursday.

Futures: Meta Platforms boomed on earnings, but megacap techs can't hide broad market rally weakness. First Republic dived again.

As American teenagers age into adulthood, they'll bring many of their favorite brands with them.

The Dow Jones reversed higher Tuesday amid key economic data. Warren Buffett stock Occidental Petroleum jumped on an analyst upgrade.

Align is Tuesday's IBD Stock Of The Day. The Invisalign-maker topped fourth-quarter expectations and ALGN stock is now eyeing two entry points.

Align Technology painted a "rosy vision" for 2023, an analyst said Thursday as ALGN stock launched to its highest point since April.